Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Day 1 - 3. Early Stages of AMD: OCT Biomarkers & New Treatments (MCQS)
Associate Professor Zhichao Wu presents on Early Stages of AMD: OCT Biomarkers & New Treatments Duration:30 minutes
Synopsis: This presentation will provide optometrists with an update on OCT imaging biomarkers in the early stages of age-related macular degeneration (AMD), and recently completed and upcoming preventative treatment trials for these individuals.
Learning Objectives
To understand OCT imaging features in the early stages of AMD and their clinical significance.
To be informed about potential preventative treatments on the horizon for individuals with the early stages of AMD.
The GDPR does not specifically apply to Optometry Australia / Optometry WA as the latter does not have an establishment in the EU nor intentionally engage in targeted marketing to EU individuals specifically. In relation to the management of member data Optometry Australia's current Privacy Act is fully compliant with the respective GDPR data regulations.
We use cookies to ensure you get the best experience on our platform and by continuing to use this site you agree that we can save them on your device. For more information, please read our privacy policy.
